MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/oncolo/oyag094

Медицинская библиотека · The oncologist · 2026

Resilience in symptom response to cancer treatment: a new lens for examining variable symptom trajectories in older adults with advanced cancer.

Zhang Zhihong, Culakova Eva, Loh Kah Poh, Heffner Kathi L, Mohamed Mostafa, Tylock Rachael G, Wells Megan, Stauffer Fiona A, Mohile Supriya, Flannery Marie

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Symptom trajectories vary among patients during cancer treatment. The National Institutes of Health resilience model, which defines resilience as the ability to resist, recover, or grow from stressors, may be useful in understanding these variations. This study examined variations in symptom trajectories through the lens of resilience among older adults with advanced cancer.

METHODS

This longitudinal quantitative study included patients aged 70 and older with advanced cancer who were receiving treatment regimens associated with a high risk of treatment-related toxicities, using data from the GAP70+ study (NCT02054741). A summary severity score of 24 symptoms from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events and functional status (measured by instrumental activities of daily living) were assessed prior to the treatment regimen initiation, at 4-6 weeks, 3 months, and 6 months later. Symptom trajectories were estimated using growth mixture models. Resilience was indicated by trajectories of resisting, recovering, or growing (ie, improving from moderate/severe to none/mild severity). Its association with functional status was examined using longitudinal linear mixed models.

RESULTS

The study included 710 patients (average age 77.2, 43.2% female, 88.0% receiving chemotherapy). Overall, 17.7% of patients showed resilience in symptom response, which was associated with higher baseline functional status (13.2 vs 12.0, P <.001) and stable functioning over 6 months. In contrast, non-resilience in symptom response was associated with a functional decline of 0.7-0.9 points without recovery by 6 months (P<.001).

CONCLUSION

Resilience in symptom response provides a novel perspective on symptom trajectory variations. Future research should explore underlying contributing factors to inform interventions that promote resilient symptom responses.

Для цитирования: Zhang Zhihong, Culakova Eva, Loh Kah Poh, Heffner Kathi L, Mohamed Mostafa, Tylock Rachael G, Wells Megan, Stauffer Fiona A, Mohile Supriya, Flannery Marie. Resilience in symptom response to cancer treatment: a new lens for examining variable symptom trajectories in older adults with advanced cancer.. The oncologist. 2026. DOI: 10.1093/oncolo/oyag094.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.